Simultaneous combined intravenous recombinant tissue plasminogen activator and endovascular therapy for hyperacute middle cerebral artery m1 occlusion.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

Volumn 17, Issue 1, 2011, Pages 115-122

  Toyota, S ^a   Sugiura, S ^b   Iwaisako, K ^b  

^a Osaka Neurological Institute   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; AGED; ANGIOPLASTY; ARTICLE; CEREBRAL ARTERY DISEASE; CLINICAL TRIAL; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANGIOPLASTY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 79960110001     PISSN: 15910199     EISSN: None     Source Type: Journal    
DOI: 10.1177/159101991101700118     Document Type: Article

References (0)